PAPER Van Camp N, Vreys R, Van Laere K, Lauwers E, Beque D, Verhoye M, Casteels C, Verbruggen A, Debyser Z, Mortelmans L, Sijbers J, Nuyts J, Baekelandt V, Van der Linden A
SEARCH RESULTS
331009 RESULTS
PAPER Na SJ, DiLella AG, Lis EV, Jones K, Levine DM, Stone DJ, Hess JF
Molecular profiling of a 6-hydroxydopamine model of Parkinson's disease.
Neurochem Res. 2010 May;35(5):761-72. PubMed: 20169470PAPER Guo X, Williams JG, Schug TT, Li X
DYRK1A and DYRK3 promote cell survival through phosphorylation and activation of SIRT1.
J Biol Chem. 2010 Apr 23;285(17):13223-32. PubMed: 20167603PAPER Wang H, Zhang W, Tang R, Zhu C, Bucher C, Blazar BR, Geng JG, Zhang C, Linden J, Wu C, Huo Y
Adenosine receptor A2A deficiency in leukocytes increases arterial neointima formation in apolipoprotein E-deficient mice.
Arterioscler Thromb Vasc Biol. 2010 May;30(5):915-22. PubMed: 20167656PAPER Stratmann G, Sall JW, Bell JS, Alvi RS, May LV, Ku B, Dowlatshahi M, Dai R, Bickler PE, Russell I, Lee MT, Hrubos MW, Chiu C
Isoflurane does not affect brain cell death, hippocampal neurogenesis, or long-term neurocognitive outcome in aged rats.
Anesthesiology. 2010 Feb;112(2):305-15. PubMed: 20098132PAPER Homsi S, Piaggio T, Croci N, Noble F, Plotkine M, Marchand-Leroux C, Jafarian-Tehrani M
Blockade of acute microglial activation by minocycline promotes neuroprotection and reduces locomotor hyperactivity after closed head injury in mice: a twelve-week follow-up study.
J Neurotrauma. 2010 May;27(5):911-21. PubMed: 20166806PAPER Li L, Willets RS, Polidori MC, Stahl W, Nelles G, Sies H, Griffiths HR
Oxidative LDL modification is increased in vascular dementia and is inversely associated with cognitive performance.
Free Radic Res. 2010 Mar;44(3):241-8. PubMed: 20166891PAPER Chakraborti AK, Garg SK, Kumar R, Motiwala HF, Jadhavar PS
Progress in COX-2 inhibitors: a journey so far.
Curr Med Chem. 2010;17(15):1563-93. PubMed: 20166930PAPER Rossé G, Schaffhauser H
5-HT6 receptor antagonists as potential therapeutics for cognitive impairment.
Curr Top Med Chem. 2010;10(2):207-21. PubMed: 20166958PAPER Haydar SN, Dunlop J
Neuronal nicotinic acetylcholine receptors- targets for the development of drugs to treat cognitive impairment associated with schizophrenia and Alzheimer's disease.
Curr Top Med Chem. 2010;10(2):144-52. PubMed: 20166959PAPER Sajjad MU, Samson B, Wyttenbach A
Heat shock proteins: therapeutic drug targets for chronic neurodegeneration?
Curr Pharm Biotechnol. 2010 Feb;11(2):198-215. PubMed: 20166961PAPER Nagai Y, Fujikake N, Popiel HA, Wada K
Induction of molecular chaperones as a therapeutic strategy for the polyglutamine diseases.
Curr Pharm Biotechnol. 2010 Feb;11(2):188-97. PubMed: 20166962PAPER Luo GR, Le WD
Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases.
Curr Pharm Biotechnol. 2010 Feb;11(2):180-7. PubMed: 20166963PAPER Laskowska E, Matuszewska E, Kuczyńska-Wiśnik D
Small heat shock proteins and protein-misfolding diseases.
Curr Pharm Biotechnol. 2010 Feb;11(2):146-57. PubMed: 20166966PAPER Correia SC, Santos RX, Cardoso S, Carvalho C, Santos MS, Oliveira CR, Moreira PI
Effects of estrogen in the brain: is it a neuroprotective agent in Alzheimer's disease?
Curr Aging Sci. 2010 Jul;3(2):113-26. PubMed: 20167003Current Filters
No filters selected